Rapid Expansion INCOG BioPharma has experienced significant growth, increasing its workforce by 450 employees in recent years and securing an $80 million expansion with a 10-year tax abatement, indicating a strong commitment to scaling operations and capacity.

Strategic Investments The company is investing heavily in expanding its sterile injectables production capacity with a $125 million investment and developing a large 90,000 square-foot facility, reflecting opportunities for suppliers and technology providers in manufacturing equipment and facility infrastructure.

Geographic Focus Centered in Fishers, Indiana, with additional facilities in California, INCOG is positioned in key U.S. biotech hubs, making it accessible for local and regional suppliers interested in biotech manufacturing collaborations.

Market Position As a rapidly growing CDMO with revenues between $100 million and $250 million and plans for ongoing capacity expansion, INCOG presents a promising target for partnerships in advanced biotechnology, packaging solutions, and regulatory compliance.

Technology & Capabilities Utilizing a robust tech stack, including ERP and cloud-based tools, INCOG emphasizes operational efficiency and quality, opening opportunities for innovative technology solutions in automation, data management, and compliance tracking to support their growth.